[
    "{\"step_by_step_thinking\": \"Pimavanserin is a non-dopaminergic therapy for Parkinson's disease psychosis. It works by selectively blocking the 5-HT2A receptor, which is thought to play a crucial role in Parkinson's disease psychosis. Clinical trials have shown that pimavanserin can significantly reduce psychotic symptoms in Parkinson's disease patients without worsening their motor symptoms.\", \"answer_choice\": \"A\"}"
]